Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 673–696 of 1,280 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Infection Prophylaxis Clear all

Conditions: Homosexuality, Male, HIV, Substance-related Disorders, Sexual Dysfunctions, Psychological
Interventions: MyPeeps Manualized Group Intervention, Standard Sexual Health Education; Behavioral
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 16 Years to 20 Years · Male only
Enrollment: 121 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: HIV Infections
Interventions: Project Enhance, Standard prevention case management (PCM); Behavioral
Lead sponsor: Fenway Community Health; Other
Eligibility: 18 Years and older · Male only
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Substance Abuse, Juvenile Delinquency, Sexual Behavior, Criminal Behavior, Violence, Depression, Anxiety, Suicide, Sexually Transmitted Infection, Educational Attainment
Interventions: Communities That Care; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 10 Years and older
Enrollment: 52,323 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Kidney Diseases, Kidney Injury, BK Virus Infection, CMV, TTV Virus
Interventions: Blood tests, TRAC( cell free DNA) and T-ID; Diagnostic Test
Lead sponsor: Transplant Genomics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 14
States / cities: Phoenix, Arizona • Los Angeles, California • Kansas City, Kansas + 10 more

Conditions: Hiv
Interventions: PrEP medication adherence mobile app; Behavioral
Lead sponsor: Environment and Health Group, Inc.; Industry
Eligibility: 20 Years to 29 Years · Male only
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: HIV Infections
Interventions: Camino Intervention; Behavioral
Lead sponsor: American University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Berkeley, California • Washington D.C., District of Columbia

Conditions: Surgical Wound Dehiscence, Wound Infection
Interventions: Negative pressure wound closure, Standard wound closure; Procedure
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 2
States / cities: Charleston, West Virginia • Morgantown, West Virginia

Conditions: HIV Infection
Interventions: Multimedia Connect, Traditional Connect; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 253 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: HIV, Sexual Risk, Sexually Transmitted Diseases, Substance Abuse, Violence, Victimization
Interventions: Test, Treat, Retain(TTR) + Women's Health CoOp (WHC), Test, Treat, Retain(TTR) only; Behavioral · Biological
Lead sponsor: RTI International; Other
Eligibility: 15 Years to 55 Years · Female only
Enrollment: 641 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Acute Lung Injury
Interventions: VIB7734, Placebo; Drug
Lead sponsor: Viela Bio; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Urinary Tract Infections
Interventions: bacterial interference; Procedure
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 15 Years to 64 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 5
States / cities: Atlanta, Georgia • Chicago, Illinois • Dallas, Texas + 1 more

Conditions: Infection, Hand Injury Wrist, Hand Injuries, Hand Injuries and Disorders, Hand Arthritis
Interventions: Systemic IV Vancomycin, Bier Block, Vancomycin; Drug · Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: HIV Infections
Interventions: Zidovudine; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: Ends 2005
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Pediatric Burns
Interventions: Culturelle, Placebo; Dietary Supplement
Lead sponsor: Shriners Hospitals for Children; Other
Eligibility: 6 Months to 18 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Allogeneic Stem Cell Transplant, Viral Infection
Interventions: Viral Specific T-cells (VSTs); Biological
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Not listed
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Influenza
Interventions: Free Air Portable Air Powered Respirator, N95 Respirator; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 49 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Bacterial Infections
Interventions: Ciprofloxacin single dose, Ciprofloxacin triple dose; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 497 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004
U.S. locations: 18
States / cities: Birmingham, Alabama • San Diego, California • San Francisco, California + 15 more

Conditions: Respiratory Tract Diseases
Interventions: DR-5001, Placebo; Biological · Other
Lead sponsor: Duramed Research; Industry
Eligibility: 17 Years and older
Enrollment: 4,040 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 2
States / cities: Great Lakes, Illinois • Fort Jackson, South Carolina

Conditions: HIV/AIDS
Interventions: Family-Based HIV prevention, Adolescent Only Health Promotion; Behavioral · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 13 Years to 18 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Catheter-Associated Urinary Tract Infection
Interventions: Bactrim, Placebo; Drug · Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 21 Years and older · Female only
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Influenza Prevention, Seasonal Influenza
Interventions: VRC-FLUMOS0116-00-VP, ALFQ; Biological · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: HIV/AIDS, Adherence, Medication, Drug Use
Interventions: Text Messaging, Peer Navigation; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: Seattle, Washington

Conditions: Simple Hand Lacerations
Interventions: cephalexin, clindamycin, placebo; Drug
Lead sponsor: State University of New York - Downstate Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 3
States / cities: Brooklyn, New York • Staten Island, New York

Conditions: Cytomegalovirus Disease
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: 1 Hour to 5 Days
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 3
States / cities: Atlanta, Georgia

Search by objective public record fields.

HIV Prevention Among Vulnerable Male Youth

Enhancing HIV Prevention by Using Behavioral Intervention Among HIV-Infected Men

The Community Youth Development Study: A Test of Communities That Care

ID-ENTITY Trial- Evaluating Serial T-ID Monitoring

Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM

El Camino HIV Prevention and Care Study

Prevention of Wound Complications After Cesarean Delivery in Obese Women Utilizing Negative Pressure Wound Therapy

Using Multimedia Technologies to Disseminate an HIV Prevention

WHC+ (Women's Health CoOp PLUS)

Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection

Prevention of Urinary Tract Infection (UTI) in Persons With Spinal Cord Injury (SCI)

Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration

A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus

Study of Culturelle in the Prophylaxis of Infection and Diarrhea

Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cell Transplant

Evaluation of Free Air Portable Air Powered Respirator

BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis

A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001

Project RAP: Family-based HIV Prevention in the Juvenile Drug Court

Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users

Antibiotic Prophylaxis for Simple Hand Lacerations

TT-CMV Observational Birth Cohort Study